Brief: Cleveland BioLabs Q2 loss per share $0.50
14/08/2017 13:12
Aug 14 (Reuters) - Cleveland BioLabs Inc CBLI.O
* Cleveland BioLabs reports second quarter 2017 financial
results and development progress
* Q2 revenue $200,000 versus $600,000
* Qtrly loss per share $0.50
Source text for Eikon: ID:nMKWg7PhHa
Further company coverage: CBLI.O
(((Bangalore.newsroom@thomsonreuters.com;);))
Recent news on Statera Biopharma
See all news20/20 Biolabs jumps on Ebola, hantavirus testing plans
Tivic Health Systems rises after deal for late-stage immunotherapy drug
Brief: Tivic Health Acquires Exclusive Worldwide Rights To Phase III TLR5 Agonist
Brief: Statera Biopharma Inc Quarterly Loss Per Share $0.20
Brief: Statera Biopharma Inc - On October 12, 2022, Co Entered A Binding Memorandum Of Understanding (“MoU”) With Holobeam Technologies, Inc